Intensive Blood Pressure Control and Cardiovascular Outcomes in Elderly Patients: A Secondary Analysis of SPRINT Study Based on a 60-Year Age Cutoff.

Background: In the original SPRINT article, age was categorized at 75 years, which was contrary to many previous clinical trials which is at 60 years.

Methods: The SPRINT trial randomized 9,361 hypertensive patients to a target blood pressure of <120 vs. <140 mm Hg (intensive vs.

Corrigendum to "NXP-2 Positive Dermatomyositis: A Unique Clinical Presentation".

[This corrects the article DOI: 10.1155/2017/4817275.].

NXP-2 Positive Dermatomyositis: A Unique Clinical Presentation.

Dermatomyositis (DM), a myopathy associated with inflammation and muscle weakness, has historically been difficult to diagnose. Recently, nuclear matrix protein (NXP-2) antibodies have been described as a myositis-specific antibody that may aid in the diagnostic evaluation. We present the case of a 21-year-old, previously healthy, African American male with DM.